VFA
ASMB icon

Virtus Fund Advisers’s Assembly Biosciences ASMB Stock Holding History

Virtus Fund Advisers’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$361K Buy
+665
New +$301K ﹤0.01% 386

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Virtus Fund Advisers's ASMB Position: Q4 2017 in Review

Virtus Fund Advisers opened a new position in Assembly Biosciences (ASMB) in Q4 2017: 665 shares worth $361K. The stake represents ﹤0.01% of the portfolio and ranks #386 among its holdings.

98 funds tracked by Wall St. Rank hold ASMB as of Q4 2017.

  • Virtus Fund Advisers held 665 shares of Assembly Biosciences worth $361K as of Q4 2017.
  • Assembly Biosciences was a new Virtus Fund Advisers position in Q4 2017.
  • Assembly Biosciences made up ﹤0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #386 holding.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.